Distributors of Lab reagents
Suppliers of Lab rec.
References of Lab monoclonals
Compare Assays lab reagents for research
Suppliers for Lab reagents
NATtrol Human Parvovirus B19 (100,000,000 IU/mL) (1 mL) |
||
NATPARVO-0005 | Zeptometrix | 1 mL |
NATtrol Influenza AH3 Stock (Quantitative) (1 mL) |
||
NATFLUAH3-STQ | Zeptometrix | 1 mL |
NATtrol Influenza Verification Panel (18 x 0.5mL) |
||
NATFVP(XP)-C | Zeptometrix | 18 x 0.5mL |
NATtrol Adenovirus Type 40 (Stool Matrix) (0.5 mL) |
||
NATADV40-GP | Zeptometrix | 0.5 mL |
NATtrol Adenovirus Type 41 (Stool Matrix) (0.5 mL) |
||
NATADV41-GP | Zeptometrix | 0.5 mL |
NATtrol Mouse Hepatitis Virus (MHV) Stock (1 mL) |
||
NATMHV-ST | Zeptometrix | 1 mL |
NATtrol Strep A Verification Panel (24 x 0.1mL) |
||
NATSAVP1-C | Zeptometrix | 24 x 0.1mL |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal SOX4 polyclonal antibody |
|||
APR13475G | Leading Biology | 0.1ml | 580.8 EUR |
Our used monoclonals in Pubmed.
Test Product |
|||
ZX001 | AAT Bioquest | 1mg | Ask for price |
Test Product |
|||
ZX002 | AAT Bioquest | 5mg | Ask for price |
Pregnancy Combo Test Card (Test in serum or urine) |
|||
INV-117 | Innovation Biotech | 4.0mm (strip in a card) 25cards/box | 0.15 EUR |
Pregnancy Combo Test Strip (Test in serum or urine) |
|||
INV-116 | Innovation Biotech | 3.0mm (single pouch) 100pouches/box | 0.05 EUR |
NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
UNCOV-40 | Atlas Link Technology | 40 Tests | 115 EUR |
Compare monoclonal lab reagents for research
Suppliers for Lab Assays
pENTR223-MEN1 vector |
||
PVT11801 | Lifescience Market | 2 ug |
pENTR223-PCM1 vector |
||
PVT11802 | Lifescience Market | 2 ug |
pENTR223-NAE1 vector |
||
PVT11805 | Lifescience Market | 2 ug |
pENTR223-PFN1 vector |
||
PVT11808 | Lifescience Market | 2 ug |
pENTR223-PMCH vector |
||
PVT11811 | Lifescience Market | 2 ug |
pENTR223-RBX1 vector |
||
PVT11838 | Lifescience Market | 2 ug |
pENTR223-IGF2 vector |
||
PVT11853 | Lifescience Market | 2 ug |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal SOX4 polyclonal antibody |
|||
APR13475G | Leading Biology | 0.1ml | 580.8 EUR |
Our used References in Pubmed.
Human sCD42b/GP1Ba , recombinant Human Recombinant Protein |
|||
S01-084 | ReliaTech | 50 µg | 196.35 EUR |
Human sCD42b/GP1Ba , recombinant Human Recombinant Protein |
|||
S01-084S | ReliaTech | 10 µg | 92.4 EUR |
Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant) |
|||
CC015-002 | GenDepot | 2ug | 351.6 EUR |
Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant) |
|||
CC015-010 | GenDepot | 10ug | 489.6 EUR |
Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant) |
|||
CC015-101 | GenDepot | 1mg | 8322 EUR |
Compare polyclonal lab reagents for research
Suppliers for Lab reagents
Rice Total RNA |
||
PLR-1004 | Zyagen | 0.05mg |
Pear Total RNA |
||
PLR-1033 | Zyagen | 0.05mg |
Dog Stomach RNA |
||
DR-302 | Zyagen | 0.1mg |
Dog Adrenal RNA* |
||
DR-501 | Zyagen | 0.05mg |
Dog Bladder RNA* |
||
DR-902 | Zyagen | 0.05mg |
Apple Total RNA |
||
PLR-1001 | Zyagen | 0.05mg |
Beans Total RNA |
||
PLR-1051 | Zyagen | 0.05mg |
Recombinant Humanp21 Recombinant Protein |
|||
92-035 | ProSci | 0.05 mg | 821.4 EUR |
TWEAK, recombinant / TNFSF12, recombinant (Human) |
|||
054-85 | PHOENIX PEPTIDE | 10 μg | 261.36 EUR |
TAGLN Recombinant Protein (Rat) (Recombinant- Tag) |
|||
RP232205 | ABM | 100 ug | Ask for price |
TAGLN2 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232208 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232211 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232214 | ABM | 100 ug | Ask for price |
TAGAP Recombinant Protein (Human) (Recombinant- Tag) |
|||
RP030880 | ABM | 100 ug | Ask for price |
TAGLN Recombinant Protein (Human) (Recombinant- Tag) |
|||
RP030883 | ABM | 100 ug | Ask for price |
Our used recombinants in Pubmed.
Anti-Urm1 (RABBIT) Antibody Antibody |
|||
GWB-D866B1 | GenWay Biotech | 500 ug | Ask for price |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | 332.4 EUR |
Compare polyclonal lab reagents for research
Suppliers for Lab ELISAs
HIV-2 Envelope |
||
hiv-140 | ProSpec Tany | 100µg |
Description: Recombinant HIV-2 Envelope |
||
HIV-1 Antibody |
||
GWB-686DB0 | GenWay Biotech | 1 ml |
HIV-1 Antibody |
||
GWB-C9E770 | GenWay Biotech | 1 ml |
HIV-1 Envelope |
||
PR-1200 | Jena Bioscience GmbH | 100µg |
Description: recombinant, E. coli |
||
HIV-2 Envelope |
||
PR-1218 | Jena Bioscience GmbH | 100µg |
Description: recombinant, E. coli |
||
HIV-1 Antibody |
||
abx023021-400l | Abbexa | 400 µl |
HIV-1 Antibody |
||
abx023021-80l | Abbexa | 80 µl |
REC-1 |
|||
ABC-TC0956 | AcceGen | 1 vial | Ask for price |
REC-2615 (HCl) |
|||
530142 | MedKoo Biosciences | 10.0mg | 295 EUR |
Rec FLA-ST |
|||
tlrl-flic-10 | InvivoGen FR | 10 µg | 295.05 EUR |
Rec FLA-ST |
|||
tlrl-flic-50 | InvivoGen FR | 50 µg | 731.85 EUR |
rec EGF (human) |
|||
4030572.01 | Bachem | 0.1 mg | 102.27 EUR |
rec EGF (human) |
|||
4030572.05 | Bachem | 0.5 mg | 271.85 EUR |
rec EGF (human) |
|||
H-7490.0100 | Bachem | 0.1mg | 194.4 EUR |
rec EGF (human) |
|||
H-7490.0500 | Bachem | 0.5mg | 457.2 EUR |
Our used antibodies in Pubmed.
Polyclonal BRD2 polyclonal antibody |
|||
APR00447G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal Hira polyclonal antibody |
|||
APR00449G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal SPI1 polyclonal antibody |
|||
APR00451G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal BMI1 polyclonal antibody |
|||
APR00457G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal CHD4 polyclonal antibody |
|||
APR00459G | Leading Biology | 0.05mg | 580.8 EUR |
Assay Lab Reagents for Research
Promoted Lab rec.
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Our used antibodies in Pubmed.
rec Leptin (human) |
|||
4038283.1 | Bachem | 1 mg | 271.85 EUR |
rec Leptin (mouse) |
|||
4038284.02 | Bachem | 0.2 mg | 102.27 EUR |
rec Leptin (mouse) |
|||
4038284.1 | Bachem | 1 mg | 271.85 EUR |
rec Leptin (human) |
|||
H-5578.0200 | Bachem | 0.2mg | 194.4 EUR |
rec Leptin (human) |
|||
H-5578.1000 | Bachem | 1.0mg | 457.2 EUR |
rec Leptin (mouse) |
|||
H-5582.0200 | Bachem | 0.2mg | 194.4 EUR |
rec Leptin (mouse) |
|||
H-5582.1000 | Bachem | 1.0mg | 457.2 EUR |
pGADT7- Rec Plasmid |
|||
PVT4025 | Lifescience Market | 2 ug | 390 EUR |
Rec 15/2615 (hydrochloride) |
|||
T37794-10mg | TargetMol Chemicals | 10mg | Ask for price |
Rec 15/2615 (hydrochloride) |
|||
T37794-1g | TargetMol Chemicals | 1g | Ask for price |
A Complex Life Habitable Zone Based On Lipid Solubility Theory
To discover doubtlessly liveable exoplanets, area missions make use of the liveable zone (HZ), which is the area round a star (or a number of stars) the place standing our bodies of water might exist on the floor of a rocky planet. Follow-up atmospheric characterization might yield biosignatures signifying life.
Although most iterations of the HZ are agnostic relating to the character of such life, a latest research argues {that a} advanced life HZ could be significantly smaller than that utilized in classical definitions. Here, I exploit a sophisticated power stability mannequin to indicate that such an HZ could be significantly wider than initially predicted given revised CO2 limits and (for the primary time) N2 respiration limits for advanced life.
The width of this advanced life HZ (CLHZ) will increase by ~35% from ~0.95-1.2 AU to 0.95-1.31 AU in our photo voltaic system. Similar extensions are proven for stars with stellar efficient temperatures between 2,600-9,000 Okay. I outline this CLHZ utilizing lipid solubility principle, diving knowledge, and outcomes from animal laboratory experiments. I additionally focus on implications for biosignatures and technosignatures. Finally, I focus on the applicability of the CLHZ and different HZ variants to the seek for each easy and sophisticated life.
Evolution of Microbial Growth Traits Under Serial Dilution
Selection of mutants in a microbial inhabitants depends upon a number of mobile traits. In serial-dilution evolution experiments, three key traits are the lag time when transitioning from hunger to development, the exponential development price, and the yield (variety of cells per unit useful resource).
Here we examine how these traits evolve in laboratory evolution experiments utilizing a minimal mannequin of inhabitants dynamics, the place the one interplay between cells is competitors for a single limiting useful resource.
We discover that the fixation chance of a useful mutation depends upon a linear mixture of its development price and lag time relative to its speedy ancestor, even below clonal interference. The relative selective strain on development price and lag time is ready by the dilution issue; a bigger dilution issue favors the difference of development price over the difference of lag time.
The mannequin exhibits that yield, nonetheless, is below no direct choice. We additionally present how the difference speeds of development and lag rely on experimental parameters and the underlying provide of mutations.
Finally, we examine the evolution of covariation between these traits throughout populations, which reveals that the inhabitants development price and lag time can evolve a nonzero correlation even when mutations have uncorrelated results on the 2 traits. Altogether these outcomes present helpful steerage to future experiments on microbial evolution.
Zika Virus Isolation, Purification, and Titration
Zika virus (ZIKV) is a vital pathogen transmitted to people by the mosquito vector Aedes aegypti. ZIKV is ready to infect a number of tissues and organs and, importantly, has been related to microcephaly and central nervous system abnormalities in fetuses and new child infants of moms uncovered to ZIKV throughout being pregnant, in addition to neurological ailments resembling Guillain-Barré syndrome in adults.
Tright here is at the moment no vaccine or drug licensed to stop or deal with ZIKV infections. The use of ZIKV isolation in illness prognosis has been largely changed by new strategies. However, virus isolation continues to be thought of as a gold customary for the detection of ZIKV and is often carried out in analysis and reference laboratories for characterization, sequencing, and quite a lot of analysis experiments together with pathogenesis, drug susceptibility, and vaccine efficacy.
The experimental procedures offered right here describe the commonest strategies used for ZIKV isolation, propagation, purification, and quantification.